CoChat
Sign Up
Cited by 39

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene

Katich, Stephanie C, Zerfass-Thome, Karin, Hoffmann, Ingrid·2001·Oncogene
DOI 10.1038/sj.onc.1204130
Open this paper in CoChat — free account

Abstract

Cdc25A is a tyrosine phosphatase that is involved in the regulation of the G1/S phase transition by activating cyclin E/Cdk2 and cyclin A/Cdk2 complexes through removal of inhibitory phosphorylations. The E6 and E7 oncoproteins of the high-risk human papillomaviruses (HPV) interact with and functionally abrogate the p53 and pRB proteins, respectively. In the present study we have investigated the regulation of the Cdc25A promoter during G1 and S-phases of the cell cycle and by the HPV-16 E7 oncoprotein. Serum induction leads to a derepression of the Cdc25A promoter and can be mediated through two E2F binding sites, E2F-A and E2F-C. While E2F-A is by both E2F1 and E2F4, E2F-C is regulated only by E2F1. The Cdc25A promoter is transactivated by the E7 oncogene of HPV-16. Furthermore, Cdc25A levels are highly increased in E7-expressing cell lines. Inducible expression of E7 leads to an immediate increase in Cdc25A protein levels. These data suggest that Cdc25A may be a critical target of HPV-16 E7 in the disruption of the G1/S phase transition.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1204130

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 28

  1. Arata Y, Fujita M, Ohtani K, Kijima S and Kato JY. . 2000 J. Biol. Chem. 275: 6337–6345. · DOI
  2. Blomberg I and Hoffmann I. . 1999 Mol. Cell. Biol. 19: 6183–6194. · DOI
  3. Botz J, Zerfass-Thome K, Spitkovsky D, Delius H, Vogt B, Eilers M, Hatzigeorgiou A and Jansen-Durr P. . 1996 Mol. Cell. Biol. 16: 3401–3409. · DOI
  4. Chen X and Prywes R. . 1999 Mol. Cell. Biol. 19: 4695–4702. · DOI
  5. Crook T, Morgenstern JP, Crawford L and Banks L. . 1989 EMBO J. 8: 513–519. · DOI
  6. Dalton S. . 1992 EMBO J. 11: 1797–1804. · DOI
  7. DeGregori J, Leone G, Miron A, Jakoi L and Nevins JR. . 1997 Proc. Natl. Acad. Sci. USA 94: 7245–7250. · DOI
  8. Funk JO, Waga S, Harry JB, Espling E, Stillman B and Galloway DA. . 1997 Genes Dev. 11: 2090–2100. · DOI · Paper page
  9. Galaktionov K and Beach D. . 1991 Cell 67: 1181–1194. · DOI
  10. Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Loda M and Beach D. . 1995 Science 269: 1575–1577. · DOI
  11. Hoffmann I, Clarke PR, Marcote MJ, Karsenti E and Draetta G. . 1993 EMBO J. 12: 53–63. · DOI
  12. Hoffmann I, Draetta G and Karsenti E. . 1994 EMBO J. 13: 4302–4310. · DOI
  13. Hoppe-Seyler F and Butz K. . 1992 Nucl. Acids Res. 20: 6701–6706. · DOI
  14. Iavarone A and Massague J. . 1999 Mol. Cell. Biol. 19: 916–922. · DOI
  15. Ioannou PA, Amemiya CT, Garnes J, Kroisel PM, Shizuya H, Chen C, Batzer MA and de Jong PJ. . 1994 Natl. Genet. 6: 84–89. · DOI
  16. Karlsson C, Katich S, Hagting A, Hoffmann I and Pines J. . 1999 J. Cell. Biol. 146: 573–584. · DOI
  17. Lam EW, Morris JD, Davies R, Crook T, Watson RJ and Vousden KH. . 1994 EMBO J. 13: 871–878. · DOI
  18. Lammer C, Wagerer S, Saffrich R, Mertens D, Ansorge W and Hoffmann I. . 1998 J. Cell. Sci. 111: 2445–2453. · DOI
  19. Lee JO, Russo AA and Pavletich NP. . 1998 Nature 391: 859–865. · DOI
  20. Lukas J, Petersen BO, Holm K, Bartek J and Helin K. . 1996 Mol. Cell. Biol. 16: 1047–1057. · DOI
  21. Nilsson I and Hoffmann I. . 2000 Prog. Cell Cycle Res., Meijer L (ed.). 4: 107–115. · DOI
  22. Ohtani K, DeGregori J and Nevins JR. . 1995 Proc. Natl. Acad. Sci. USA 92: 12146–12150. · DOI
  23. Pagano M, Pepperkok R, Verde F, Ansorge W and Draetta G. . 1992 EMBO J. 11: 961–971. · DOI
  24. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS and Piwnica-Worms H. . 1997 Science 277: 1501–1505. · DOI · Paper page
  25. Sadhu K, Reed SI, Richardson H and Russell P. . 1990 Proc. Natl. Acad. Sci. USA 87: 5139–5143. · DOI
  26. Schulze A, Zerfass K, Spitkovsky D, Middendorp S, Berges J, Helin K, Jansen-Durr P and Henglein B. . 1995 Proc. Natl. Acad. Sci. USA 92: 11264–11268. · DOI
  27. Vigo E, Muller H, Prosperini E, Hateboer G, Cartwright P, Moroni MC and Helin K. . 1999 Mol. Cell. Biol. 19: 6379–6395. · DOI
  28. zur Hausen H. . 1999 Semin. Cancer Biol. 9: 405–411. · DOI

Cited by

See all 39

Metadata

Authors
Katich, S. C., Zerfass-Thome, K., & Hoffmann, I.
Venue
Oncogene
Publisher
Springer Science and Business Media LLC
Published
2001-02-01
Volume
20
Issue
5
Pages
543-550
ISSN
  • 0950-9232
  • 1476-5594
DOI
10.1038/sj.onc.1204130
Cited by
39
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review